Cotellic (cobimetinib tablets – Genentech/Roche) — Cigna

Initial criteria

• Patient age ≥ 18 years
• Patient has ONE of the following: Langerhans cell histiocytosis OR Erdheim-Chester disease OR Rosai-Dorfman disease

Approval duration

1 year